1Zhou C, Wu YL, Chen G, et al. Erlotinib versus chemotherapy as first -line treatment for patients with advanced EGFR mutation - positive non - small - cell lung cancer ( OPTIMAL, CTONG - 0802 ) : A multicentre, open - label, randomised, phase 3 study [ J ]. Lancet Oncol,201 1,12(8) :735 -742.
2Paz- Ares LG, De Marinis F, Dediu M, et al. Final overall survival results of the phase Ill study of maintenance pemetrexed versus pla- cebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non - small - cell lung cancer [ J]. J Clin Oncol,2013,31 (23) :2895 - 2902.
3Scaglintti GV,Parikh P,Von Pawel J,et al. Phase study compa- ring cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy - naive patients with advanced - stage non - small - cell lung cancer[ J].Clin Onco1,2008,26 ( 21 ) :3543 - 3551.
4Mok TS, Wu YL, Thongprasert S, et al. Gefitinib or carboplatin - paclitaxel in pulmonary adenocarcinoma[ J]. N Engl J Med,2009, 361 (10) :947 -957.
5Zhang L, Ma S, Song X, et al. Gefitinib versus placebo as mainte- nance therapy in patients with locally advanced or metastatic non - small - (:ell lung cancer ( INFORM ;C - TONG 0804) :A multicen- ire,double- blind randomised phase 3 trial [ J]. Lancet Oncal, 2012,13(5 ) :466 -475.
6Serizawa M, Takahashi T, Yamamoto N, et al. Combined treatment with erlotinib and a transforming growth factor - 13 type I receptor inhibitor effectively suppresses the enhanced motility of erlotinib - resistant non - small - cell lung cancer cells [ J ]. J Thorac Oncol, 2013,8(3) :259 -269.
7Wu Y,Zheng Y, Shen Z,et al. Endostar combined with radiotherapy increases radiation sensitivity by decreasing the expression of TGF - 131, HIF - 1 ct and bFGF[ J ]. Exp Ther Med ,2014,7 (4) :911 - 916.
8Barlesi F,Scherpereel A, Rittmeyer A, et al. Randomized phase lll trial of maintenance bevacizumab with or without pemetrexed after first- line induction with bevacizumab, cisplatin, and pemetrexed in advanced nonsquamous non - small - cell lung cancer[ J ]. J Clin Oncol,2013,31 (24) :3004 -3011.
9Wu YL, Lee JS, Thongprasert S, et al. Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non - small - cell lung cancer ( FASTACT - 2 ) : Arandomised, double - blindtrial [ J ]. Lancet Onco1,2013,14 ( 8 ) :777 - 786.
10Kato T,et al. The combination of erlotinib and bevacizumab pro- longs PFS in patients with EGFR - mutant NSCLC [ J ]. ASCO, 2014,80:05.
